Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Fidaxomicinis a macrolide antibiotic that plays a role in the treatment of Clostridium difficile associated diarrhea (CDAD) by inhibiting the bacterial RNA polymerase to combat ref···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：389
Fidaxomicin exerts its pharmacological effects primarily through the inhibition of bacterial RNA polymerase and is frequently prescribed for the treatment of diarrheal episodes att···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：396
DIFICID is a medication used to treat Clostridium difficile associated diarrhea, and its use in specific populations requires particular caution.Use in Specific Populations?For cer···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：326
Fidaxomicin is a prescription medication that should be administered under the guidance of a physician. Patients are advised to undergo regular examinations, observe any discomfort···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：300
Adlumiz is a novel oral pharmaceutical agent utilized primarily in the management of weight and muscle wasting resulting from malignancies. A plethora of clinical trials have corro···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：346
Fidaxomicin is a pharmacological agent specifically indicated for the treatment of Clostridium difficile associated diarrhea, suitable for adult and pediatric patients aged 6 month···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：395
Fidaxomicin is primarily employed for the management of Clostridium difficile-associated diarrhea (CDAD). This medication exhibits low systemic absorption, lacks efficacy against d···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：391
Anamorelinis a medication utilized in the treatment of specific ailments, and like all medications, Anamorelinmay potentially elicit some adverse effects. Patients should be well i···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：309
Fidaxomicin is a pharmaceutical for the treatment of difficile-associated diarrhea (CDAD), indicated for adult and pediatric patients aged 6 months and older. CDAD is a gastrointes···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：406
fidaxomicin, a pharmacological agent renowned for its efficacy against Clostridium difficile infection, operates by impeding the metabolic pathways of the bacterium, thus inhibitin···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：371
Fidaxomicin is a pharmaceutical agent specifically designed to combat infections caused by Clostridium difficile. Prior to initiating treatment with Fidaxomicin, patients are advis···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：323
Sotorasib, a targeted therapeutic agent for advanced non-small cell lung cancer (NSCLC) patients harboring the KRAS G12C mutation, exerts its efficacy by specifically inhibiting th···【more】
Article source：Captain MedicineRelease date：2024-07-09Recommended：436
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
